ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Thioridazine protects against disturbed flow-induced atherosclerosis by inhibiting RhoA/YAP-mediated endothelial inflammation

Jiang, Min-chun; Ding, Huan-yu; Huang, Yu-hong; Cheng, Chak Kwong; Lau, Chi Wai; Xia, Yin; Yao, Xiao-qiang; Wang, Li; Huang, Yuy
Acta Pharmacologica Sinica2023-10DOI: 10.1038/s41401-023-01102-w
1被引27阅读
引用收藏
分享

摘要

Atherosclerotic diseases remain the leading cause of adult mortality and impose heavy burdens on health systems globally. Our previous study found that disturbed flow enhanced YAP activity to provoke endothelial activation and atherosclerosis, and targeting YAP alleviated endothelial inflammation and atherogenesis. Therefore, we established a luciferase reporter assay-based drug screening platform to seek out new YAP inhibitors for anti-atherosclerotic treatment. By screening the FDA-approved drug library, we identified that an anti-psychotic drug thioridazine markedly suppressed YAP activity in human endothelial cells. Thioridazine inhibited disturbed flow-induced endothelial inflammatory response in vivo and in vitro. We verified that the anti-inflammatory effects of thioridazine were mediated by inhibition of YAP. Thioridazine regulated YAP activity via restraining RhoA. Moreover, administration of thioridazine attenuated partial carotid ligation- and western diet-induced atherosclerosis in two mouse models. Overall, this work opens up the possibility of repurposing thioridazine for intervention of atherosclerotic diseases. This study also shed light on the underlying mechanisms that thioridazine inhibited endothelial activation and atherogenesis via repression of RhoA-YAP axis. As a new YAP inhibitor, thioridazine might need further investigation and development for the treatment of atherosclerotic diseases in clinical practice.

学科与关键词

关键词
atherosclerosisendotheliuminflammationdisturbed flowYes-associated proteinthioridazine
相关
加载中…
  • Curaxin CBL0137 inhibits endothelial inflammation and atherogenesis via suppression of the Src-YAP signalling axis
    Ding, Huanyu; Jiang, Minchun; Lau, Chi Wai; Luo, Jianfang; Chan, Andrew M. M.; Wang, Li*; Huang, Yu*British Journal of Pharmacology, 2023, 180(8): 1168-1185.被引 1
  • Deletion of BACH1 Attenuates Atherosclerosis by Reducing Endothelial Inflammation
    Jia, Mengping; Li, Qinhan; Guo, Jieyu; Shi, Weihao; Zhu, Lei; Huang, Yijun; Li, Yongbo; Wang, Li; Ma, Siyu; Zhuang, Tao; Wang, Xiaoqun; Pan, Qi; Wei, Xiangxiang; Qin, Yue; Li, Xiaobo; Jin, Jiayu; Zhi, Xiuling; Tang, Jingdong; Jing, Qing; Li, Shanqun; Jiang, Lindi; Qu, Lefeng; Osto, Elena; Zhang, Jianyi; Wang, Xinhong*; Yu, Bo*; Meng, Dan*Circulation Research, 2022, 130(7): 1038-1055.被引 48
  • The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway
    Diao, Hongtao; Cheng, Jiawen; Huang, Xueying; Huang, Bingying; Shao, Xiaoqi; Zhao, Jingjing; Lan, Dingming; Zhu, Qing; Yan, Meiling; Zhang, Yue; Rong, Xianglu; Guo, Jiao*Journal of Ethnopharmacology, 2022, 293: 115261.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Acta Pharmacologica Sinica
发表日期
2023-10
卷期
第 44 卷, 第 10 期
页码
1977-1988
DOI
10.1038/s41401-023-01102-w
语言
ENGLISH
期刊收录
CAST-P
成果收录
SCIE
资助标注
Hong Kong Research Grants Council [SRFS2021-4S04, 14112919, 14164817, 14109720]; Hong Kong PhD Fellowship Scheme, and Health and Medical Research Fund [07181286]

作者

  • J

    Jiang, Min-chun (第一作者)

    chinese univ hong kong

  • D

    Ding, Huan-yu

    chinese univ hong kong

查看全部 9 位作者收起作者
  • H

    Huang, Yu-hong

  • C

    Cheng, Chak Kwong

  • L

    Lau, Chi Wai

    chinese univ hong kong

  • X

    Xia, Yin

    chinese univ hong kong

  • Y

    Yao, Xiao-qiang

    chinese univ hong kong

  • W

    Wang, Li

  • H

    Huang, Yu

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417